Additional COVID-19 Vaccine Could Be Approved
A review for the Moderna COVID-19 vaccine was released Tuesday essentially ensuring the FDA will approve it, according to reports. It’s a new analysis from the FDA that found the vaccine was 94.5% effective at least 14 days after the second dose was given. This is a similar efficacy to Pfizer/Biontech’s vaccine.